This search looks for keywords in all of the website’s content. Search tips
Filter by
Massive amounts of data are generated on a daily basis that could potentially be harnessed to support medicines regulation. The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) set up a joint task force to describe the big data landscape from a regulatory perspective and identify practical steps for the European medicines...
HumanVeterinaryCorporateData on medicinesInnovationResearch and development
EventHumanVeterinaryCorporateData on medicinesInnovationResearch and development
During the 2020-23 COVID-19 public health emergency, the European Medicines Agency (EMA) provided guidance for medicine developers and pharmaceutical companies to help speed up development and approval for COVID-19 medicines and address regulatory challenges arising from the pandemic.
HumanCOVID-19Clinical trialsCompassionate useRegulatory and procedural guidanceMedicine shortagesResearch and developmentScientific advice
EventHumanVeterinaryCorporateData on medicinesInnovationResearch and development
NewsHumanCOVID-19Research and development
NewsHumanCOVID-19Research and development
NewsHumanCOVID-19Research and developmentVaccines
Press releaseHumanCOVID-19MedicinesResearch and development
Press releaseHumanCOVID-19Clinical trialsQuality of medicinesResearch and developmentVaccines
Press releaseHumanCOVID-19Clinical trialsMedicinesResearch and development